Fortitude Family Office’s Medifast MED Stock Holding History

Fortitude Family Office’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-18	Closed	-$191	–	2705
2026 Q2	$191	Buy	+18	New	+$208	﹤0.01%	2121
2025 Q4	–	Sell	-704	Closed	-$9.62K	–	2044
2025 Q3	$9.62K	Buy	704 +34	+5%	+$475	﹤0.01%	581
2025 Q2	$9.41K	Buy	+670	New	+$8.8K	﹤0.01%	578

Other funds holding MED

SIM

SummerHaven Investment Management Stamford, Connecticut $137M AUM 42.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

MAFA

MJT & Associates Financial Advisory Monteviceo, Minnesota $155M AUM 15.7% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Fortitude Family Office's MED Position: Q3 2026 in Review

Fortitude Family Office sold out of Medifast (MED) in Q3 2026, closing a stake of 18 shares — an estimated $191 sold.

Fortitude Family Office first reported a position in MED in Q2 2025 and held it in 3 quarters. The position peaked at $9.62K in Q3 2025. 6 funds tracked by Wall St. Rank hold MED as of Q3 2026.

Fortitude Family Office reported no remaining Medifast position as of Q3 2026 after selling out during the quarter.
Fortitude Family Office sold 18 Medifast shares in Q3 2026, an estimated $191.
Fortitude Family Office first reported a position in Medifast in Q2 2025 and held it in 3 quarters.
Fortitude Family Office's Medifast position peaked at $9.62K in Q3 2025.
6 funds tracked by Wall St. Rank held Medifast as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.